Request Deal Involvement
ARS Pharmaceuticals to merge with Silverback Therapeutics in a $144m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Canale Communications
financial advisors
Leerink Partners
legal advisors
Cooley
legal advisors
Kirkland & Ellis
legal advisors
Inceptiv Law
or
Principals
target
SILVERBACK THERAPEUTICS
bidder
ARS PHARMACEUTICALS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite